RadNet, Inc. (RDNT): Net Income
-$18.65M
Year ended 2025-12-31
-$21.12M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$18.65M | n/m | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | $2.79M | -8.2% | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | $3.04M | -71.4% | 2026-03-02, From 2023-01-01 |
| 2022-12-31 | $10.65M | -56.9% | 2025-03-03, From 2022-01-01 |
| 2021-12-31 | $24.73M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$14.84M | n/m | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $14.76M | -54.2% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $32.24M | n/m | 2021-03-16, From 2018-01-01 |
| 2017-12-31 | $53.0K | -99.3% | 2020-03-16, From 2017-01-01 |
| 2016-12-31 | $7.23M | -6.2% | 2019-03-18, From 2016-01-01 |
| 2015-12-31 | $7.71M | n/c | 2018-03-19, From 2015-01-01 |
| 2014-12-31 | $10.66M | -7.6% | 2017-03-31, From 2014-01-01 |
| 2013-12-31 | $11.54M | -6.9% | 2016-03-30, From 2013-01-01 |
| 2012-12-31 | $12.39M | +54.7% | 2015-03-31, From 2012-01-01 |
| 2011-12-31 | $8.01M | -4.5% | 2014-03-31, From 2011-01-01 |
| 2010-12-31 | $8.39M | n/c | 2013-11-13, From 2010-01-01 |
| 2009-12-31 | -$2.27M | n/a | 2012-03-13, From 2009-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| RadNet, Inc. (RDNT) | 2025-12-31 | -$18.65M | n/m |
| Natera, Inc. (NTRA) | 2025-12-31 | -$208.16M | n/m |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | -$986.20M | n/m |
| Guardant Health, Inc. (GH) | 2025-12-31 | -$416.28M | n/m |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | -$68.09M | n/m |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $66.35M | +174.9% |
| CareDx, Inc. (CDNA) | 2025-12-31 | -$21.35M | n/m |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $992.00M | +13.9% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | -$24.16M | n/m |
Compare RDNT, NTRA, FTRE, GH side by side · Screen every company in Services-Medical Laboratories ↗